Rising costs hold up drug discovery

Rising drug costs: the impact on dermatology.

In the US prescription drug costs are rising faster than any other component of health care expenditures, and show no signs of slowing. Spending on prescription drugs has been estimated by the Health Care Finance Administration (HCFA) to be rising by approximately 12% per year, more than twice the rate for national health care expenditures (5.1%). Factors driving the rise in prescription drug c...

Rising Legal Costs

A continuing, oft-expressed concern about the legal system, in the English-speaking world at least, is the rising cost of legal services, whether civil or criminal. Given the labour-intensive nature of legal services, this is not surprising to an economist, as we discuss below. In order to be effective, policy must be informed before reforms are considered, lest reforming zeal be dissipated ine...

Rising health care costs.

Ethnobotany, Ethnopharmacology and Drug Discovery

     This manuscript is a review of a number of ethnobotany and ethnopharmacology texts and papers in order to arrive at current understanding and scope of ethnobotany and ethnopharmacology. It includes either a brief definition of both fields and presenting some examples on them. Also it has a glimpse on the geographical coverage of research works throughout the world, important issue of prope...

Crying Over Spilt Milk: Sunk Costs, Fairness Norms and the Hold-up Problem

This article explores a possible connection between two behavioural anomalies in economics, the observed responsiveness of individual decision makers to sunk costs, and the apparent failure of backward induction to predict outcomes in experimental bargaining games. In particular, we show that under some conditions, a ‘sunk cost sensitive’ fairness norm can evolve in such environments. Under thi...